Market Cap N/A
Revenue (ttm) N/A
Net Income (ttm) N/A
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume 10,245
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Radiopharm Theranostics Limited a clinical-stage radiotherapeutics company, engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas with high unmet medical needs. The company develops several products, including RAD101, a pivalate brain metastasis diagnostic; RAD102, a pivalate therapeutic; RAD201a, a Nano-mAb HER-2 breast diagnostic; RAD202, a Nano-mAb HER-2 breast therapeutic; RAD203, a Nano-mAb PDL1 non-small cell lung diagnostic; a...

Industry: Biotechnology
Sector: Healthcare
Phone: 61 3 9824 5254
Fax: 61 3 9822 7735
Address:
62 Lygon Street, Level 3, Carlton, Australia
Lalalilala
Lalalilala Oct. 25 at 8:45 PM
$RADX @Radiolsotop25, Hi loyal contributor! If you could sometimes copy and paste text instead of putting PDFs, it would allow some of us to be able to translate into our language and to be aware of what you want to share.... I'm already going to write that I did very badly at school and that English was one of my worst nightmares.. I regret it today but I no longer want to learn. Google translate makes it very easy for me. Thank you for everything. I didn't read what you thought about the suspension of trading for 3 days for the announcement of an offering that would have allowed us all to buy back much lower than our average at that time... somewhere the long-term shareholders are losing out for the moment.... I find that management has shown a certain amount of contempt towards us. ? What do you think?
1 · Reply
RadioIsotope25
RadioIsotope25 Oct. 25 at 1:51 PM
Radiopharm has seen breast cancer tumour reductions in first-phase trials $RADX https://hotcopper.com.au/news/asx-news/151430/radiopharm-has-seen-breast-cancer-tumour-reductions-in-first-phase-trials/
0 · Reply
RadioIsotope25
RadioIsotope25 Oct. 24 at 10:49 PM
Home Run opportunity $RADX
0 · Reply
RadioIsotope25
RadioIsotope25 Oct. 24 at 10:36 PM
0 · Reply
uppalapatikc
uppalapatikc Oct. 24 at 10:32 PM
$RADX I have a strong feeling that some people are pumping this stock and dumping it...just my 2 cents
1 · Reply
RadioIsotope25
RadioIsotope25 Oct. 24 at 9:51 PM
$RADX Should see a nice upstream with Her2 data pending on 75 mci. Very high tumor uptake!
0 · Reply
Lalalilala
Lalalilala Oct. 24 at 7:52 PM
$RADX Soon 10,000 in my bag 😁. I waited as long as it took. 1 weekend, 1 month, 1 year, 3 years. And I certainly wouldn't sell for $13 either. Seriously!
1 · Reply
RadioIsotope25
RadioIsotope25 Oct. 24 at 7:11 PM
$RADX Her2 market for RAD202 is
0 · Reply
RadioIsotope25
RadioIsotope25 Oct. 24 at 5:29 PM
BMS enters radiopharma race with $4.1B acquisition of RayzeBio $RADX https://www.fiercebiotech.com/biotech/bms-enters-radiopharma-race-41b-acquisition-rayzebio-just-3-months-after-biotechs-ipo
0 · Reply
RadioIsotope25
RadioIsotope25 Oct. 24 at 5:28 PM
Lutetium-177 With RT Prolongs Survival in Prostate Cancer $RADX https://www.medscape.com/viewarticle/lutetium-177-rt-prolongs-survival-prostate-cancer-2025a1000qcc
0 · Reply
Latest News on RADX
No data available.
Lalalilala
Lalalilala Oct. 25 at 8:45 PM
$RADX @Radiolsotop25, Hi loyal contributor! If you could sometimes copy and paste text instead of putting PDFs, it would allow some of us to be able to translate into our language and to be aware of what you want to share.... I'm already going to write that I did very badly at school and that English was one of my worst nightmares.. I regret it today but I no longer want to learn. Google translate makes it very easy for me. Thank you for everything. I didn't read what you thought about the suspension of trading for 3 days for the announcement of an offering that would have allowed us all to buy back much lower than our average at that time... somewhere the long-term shareholders are losing out for the moment.... I find that management has shown a certain amount of contempt towards us. ? What do you think?
1 · Reply
RadioIsotope25
RadioIsotope25 Oct. 25 at 1:51 PM
Radiopharm has seen breast cancer tumour reductions in first-phase trials $RADX https://hotcopper.com.au/news/asx-news/151430/radiopharm-has-seen-breast-cancer-tumour-reductions-in-first-phase-trials/
0 · Reply
RadioIsotope25
RadioIsotope25 Oct. 24 at 10:49 PM
Home Run opportunity $RADX
0 · Reply
RadioIsotope25
RadioIsotope25 Oct. 24 at 10:36 PM
0 · Reply
uppalapatikc
uppalapatikc Oct. 24 at 10:32 PM
$RADX I have a strong feeling that some people are pumping this stock and dumping it...just my 2 cents
1 · Reply
RadioIsotope25
RadioIsotope25 Oct. 24 at 9:51 PM
$RADX Should see a nice upstream with Her2 data pending on 75 mci. Very high tumor uptake!
0 · Reply
Lalalilala
Lalalilala Oct. 24 at 7:52 PM
$RADX Soon 10,000 in my bag 😁. I waited as long as it took. 1 weekend, 1 month, 1 year, 3 years. And I certainly wouldn't sell for $13 either. Seriously!
1 · Reply
RadioIsotope25
RadioIsotope25 Oct. 24 at 7:11 PM
$RADX Her2 market for RAD202 is
0 · Reply
RadioIsotope25
RadioIsotope25 Oct. 24 at 5:29 PM
BMS enters radiopharma race with $4.1B acquisition of RayzeBio $RADX https://www.fiercebiotech.com/biotech/bms-enters-radiopharma-race-41b-acquisition-rayzebio-just-3-months-after-biotechs-ipo
0 · Reply
RadioIsotope25
RadioIsotope25 Oct. 24 at 5:28 PM
Lutetium-177 With RT Prolongs Survival in Prostate Cancer $RADX https://www.medscape.com/viewarticle/lutetium-177-rt-prolongs-survival-prostate-cancer-2025a1000qcc
0 · Reply
RadioIsotope25
RadioIsotope25 Oct. 24 at 2:31 PM
$RADX RAD402 formed between MD anderson and Radiopharm Theranostics will enter the clinic end of year for Prostate Cancer. MD Anderson is the best cancer center in the world. $ATNM $LNTH $CLRB $CATX
1 · Reply
dachshund36
dachshund36 Oct. 24 at 2:11 PM
$RADX With projected sales exceeding $500M per year from just one of their drugs, this stock has lots of room to grow over its $60M MC. https://radiopharmtheranostics.com/clinical-update-and-capital-raising-october-20th-2025/
0 · Reply
biospeculator
biospeculator Oct. 24 at 1:56 PM
$RADX Big fake offer by a hedge fund in order to scare people into selling. I just swept everything from $5.3-$5.5. If news Monday pops this to $7+ I will trade these shares. If not then I have them for the Her2 trial results at end of year.
0 · Reply
RadioIsotope25
RadioIsotope25 Oct. 24 at 12:46 PM
First dosing for the prostate drug coming soon. Normally 1 asset would value a company at $50 million and they have 6.. Have to be patient end of January/February this will be multiples higher IMO. $RADX
1 · Reply
biospeculator
biospeculator Oct. 24 at 12:18 PM
$RADX I would hope RADX management will disclose great results Monday morning after just raising capital and based on the time and day of release. Have a great weekend.
1 · Reply
e17
e17 Oct. 24 at 2:08 AM
$RADX 80% short today, granted low volume but we ended up green by 3% then nearly 10% green ah and were getting the readout Monday. See you later 5s 6s and 7s!
1 · Reply
Manpreet00
Manpreet00 Oct. 24 at 1:32 AM
$RADX so is there any data read out this year ? Someone said it’s happening on Monday
1 · Reply
biospeculator
biospeculator Oct. 23 at 7:32 PM
$RADX I would like to comment on the comments from Brookline Capital. Their comments imo are worthless. Why? They simply brought their target down by the exact percentage of issued shares/dilution. They posted the incorrect number of outstanding shares. They acknowledged the developing pipeline and significance of Her2 but don't include any of the pipeline in their "analysis" except RAD101. They didn't include the additional cash but acknowledge the receipt thereof. IMO it's grade school analysis that reeks of being upset that they didn't get a piece of the deal. I place absolutely zero credibility on their analysis. Hopefully my analysis of their analysis was more competent and confusing than theirs, lol.
3 · Reply
RadioIsotope25
RadioIsotope25 Oct. 23 at 4:27 PM
$RADX Lantheus average purchase price $9.10
0 · Reply
RadioIsotope25
RadioIsotope25 Oct. 23 at 2:44 PM
Dr Williams on Remaining Unmet Needs in HER2+ Breast Cancer | OncLive $RADX https://www.onclive.com/view/dr-williams-on-remaining-unmet-needs-in-her2-breast-cancer
0 · Reply
RadioIsotope25
RadioIsotope25 Oct. 23 at 1:39 PM
Lantheus has infused near $20 million past 18 months through stock purchases. asset purchases and business deals in past 18-mos. $RADX $LNTH
0 · Reply
RadioIsotope25
RadioIsotope25 Oct. 23 at 1:21 PM
$RADX Massive upside here in Lu-177
0 · Reply